Circulating tumor cells in breast cancer: Advanced tools for "tailored" therapy?

Proceedings of the National Academy of Sciences of the United States of America

Volumn 103, Issue 46, 2006, Pages 17073-17074

  Cristofanilli, Massimo ^a   Mendelsohn, John ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMATINIB; TRASTUZUMAB;

BREAST CANCER; CANCER CHEMOTHERAPY; CHRONIC MYELOID LEUKEMIA; DRUG TARGETING; HUMAN; NOTE; ONCOGENE; ONCOGENE NEU; PRIORITY JOURNAL; PROGNOSIS; TREATMENT OUTCOME; TUMOR CELL;

BREAST NEOPLASMS; CELL MOVEMENT; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; RECEPTOR, ERBB-2; RECEPTORS, CELL SURFACE; TUMOR MARKERS, BIOLOGICAL;

EID: 33751249337     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.0608651103     Document Type: Note

References (20)

1. Slamon DJ, Leyland-Jones B, Shak S, Fuchs H, Paton V, Bajamonde A, Fleming T, Eiermann W, Wolter J, Pegram M, et al. (2001) N Engl J Med 344:783-792.
2. O'Brien SG, Guilhot F, Larson RA, Gathmann I, Baccarani M, Cervantes F, Cornelissen JJ, Fischer T, Hochhaus A, Hughes T, et al. (2003) N Engl J Med 348:994-1004.
3. Meng S, Tripathy D, Shete S, Ashfaq R, Saboorian H, Haley B, Frenkel E, Euhus D, Leitch M, Osborne C, et al. (2006) Proc Natl Acad Sci USA 103:17361-17365.
4. Yarden Y, Sliwkowski M (2001) Nat Rev Mol Cell Biol 2:127-137.
5. Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL (1987) Science 235:177-182.
6. Piccart-Gebhart MJ, Procter M, Leyland-Jones B, Goldhirsch A, Untch M, Smith I, Gianni L, Baselga J, Bell R, Jackisch C, et al. (2005) N Engl J Med 353:1659-1672.
7. Romond EH, Perez EA, Bryant J, Suman VJ, Geyer CE, Jr, Davidson NE, Tan-Chiu E, Martino S, Paik S, Kaufman PA, et al. (2005) N Engl J Med 353:1673-1684.
8. Lorincz T, Toth J, Badalian G, Timar J, Szendroi M (2006) Pathol Oncol Res 12:149-152.
9. Meng S, Tripathy D, Shete S, Ashfaq R, Haley B, Perkins S, Beitsch P, Khan A, Euhus D, Osborne C, et al. (2004) Proc Natl Acad Sci USA 101:9393-9398.
10. Tanner M, Isola J, Wiklund T, Erikstein B, Kellokumpu-Lehtinen P, Malmstrom P, Wilking N, Nilsson J, Bergh J (2006) J Clin Oncol 24:2428-2436.
11. Urban P, Vuaroqueaux V, Labuhn M, Delorenzi M, Wirapati P, Wight E, Senn HJ, Benz C, Eppenberger U, Eppenberger-Castori S (2006) J Clin Oncol 24:4245-4425.
12. Wang SE, Narasanna A, Perez-Torres M, Xiang B, Wu FY, Yang S, Carpenter G, Gazdar AF, Muthuswamy SK, Arteaga CL (2006) Cancer Cell 10:25-38.
13. Saez R, Molina MA, Ramsey EE, Rojo F, Keenan EJ, Albanell J, Lluch A, Garcia-Conde J, Baselga J, Clinton GM (2006) Clin Cancer Res 12:424-431.
14. Meng S, Tripathy D, Frenkel EP, Shete S, Naftalis EZ, Huth JF, Beitsch PD, Leitch M, Hoover S, Euhus D, et al (2004) Clin Cancer Res 10:8152-8162.
15. Cristofanilli M, Budd GT, Ellis MJ, Stopeck A, Matera J, Miller MC, Reuben JM, Doyle GV, Allard WJ, Terstappen LW, Hayes DF (2004) N Engl J Med 351:781-791.
16. Cristofanilli M, Hayes DF, Budd GT, Ellis MJ, Stopeck A, Reuben JM, Doyle GV, Matera J, Allard WJ, Miller MC, et al. (2005) J Clin Oncol 23:1420-1430.
17. Xenidis N, Perraki M, Kafousi M, Apostolaki S, Bolonaki I, Stathopoulou A, Kalbakis K, Androulakis N, Kouroussis C, Pallis T, et al. (2006) J Clin Oncol 24:3756-3762.
18. Speicher MR, Carter NP (2005) Nat Rev Genet 6:782-792.
19. Smirnov DA, Foulk BW, Doyle GV, Connelly MC, Terstappen LW, O'Hara SM (2006) Cancer Res 66:2918-2922.
20. Naume B, Borgen E, Tossvik S, Pavlak N, Oates D, Nesland JM (2004) Cytotherapy 6:244-252.